Old Web
English
Sign In
Acemap
>
authorDetail
>
Yosuke Hirasawa
Yosuke Hirasawa
Cedars-Sinai Medical Center
Internal medicine
Medicine
Atezolizumab
Oncology
Sipuleucel-T
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate Cancer.
2021
Yosuke Hirasawa
Ian Pagano
Jeffrey Huang
Yuka Sasaki
Kaoru Murakami
Charles J. Rosser
Hideki Furuya
Show All
Source
Cite
Save
Citations (0)
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.
2021
Journal for ImmunoTherapy of Cancer
Tanya B. Dorff
Yosuke Hirasawa
Jared David Acoba
Ian Pagano
David Jon Tamura
Sumanta K. Pal
Minlu Zhang
Rebecca Waitz
Abhilash Dhal
Winston A. Haynes
John Shon
Mark C. Scholz
Hideki Furuya
Owen T M Chan
Jeffrey Huang
Charles J. Rosser
Show All
Source
Cite
Save
Citations (0)
Phase Ib study assessing different sequencing regimens of atezolizumab (anti-PD-L1) and sipuleucel-T (SipT)in patients who have asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
2020
Journal of Clinical Oncology
Charles J. Rosser
Yosuke Hirasawa
Jared David Acoba
David Jon Tamura
Sumanta K. Pal
Jeffrey Huang
Mark C. Scholz
Tanya B. Dorff
Show All
Source
Cite
Save
Citations (4)
1